Basal GangliaDopamineReceptors, Dopamine D2Basal Ganglia DiseasesReceptors, Dopamine D1Dopamine AgonistsDopamine AntagonistsReceptors, DopamineGangliaReceptors, Dopamine D3Retinal Ganglion CellsGlobus PallidusGanglia, SpinalBasal Ganglia HemorrhageDopamine AgentsDopamine Plasma Membrane Transport ProteinsCorpus StriatumGanglia, SympatheticGanglia, AutonomicNeuronsNeural PathwaysTrigeminal GanglionPutamenBasal Ganglia Cerebrovascular DiseaseReceptors, Dopamine D5Ganglia, ParasympatheticSubstantia NigraDopamine Uptake InhibitorsBrainGanglia, SensoryCaudate NucleusSubthalamic NucleusDopamine beta-HydroxylaseNeostriatumMagnetic Resonance ImagingLevodopaThalamusRats, Sprague-DawleyQuinpiroleNerve NetBenzazepinesStellate GanglionParkinson DiseaseOxidopamineAction PotentialsParkinsonian DisordersGanglia, InvertebrateRacloprideSpiral GanglionNucleus AccumbensNodose GanglionTyrosine 3-MonooxygenaseDystoniaBehavior, AnimalApomorphineParkinson Disease, SecondaryCerebral CortexHaloperidolModels, NeurologicalDopaminergic NeuronsSynaptic TransmissionBrain MappingMovement DisordersDopamine and cAMP-Regulated Phosphoprotein 32ChoreaMotor ActivityElectric StimulationCocaineSalicylamidesRewardMesencephalonSuperior Cervical GanglionSulpirideAmphetamineHomovanillic AcidRetinaAntiparkinson AgentsEntopeduncular NucleusStereotyped BehaviorFinchesNeural InhibitionTime FactorsAxonsDeep Brain Stimulationgamma-Aminobutyric AcidNerve Tissue ProteinsMicrodialysisHypokinesiaVocalization, AnimalDystonic DisordersDyskinesia, Drug-InducedReaction TimeAnalysis of VarianceDihydroxyphenylalaninePrefrontal CortexInterneuronsVentral Tegmental AreaCebusCerebellumElectrophysiology